The focus of our project is to be able to detect and track the progress of chemotherapy of glioblastoma using MGMT. Our solution is to create a cost-effective and efficient biosensor which has two parts, measuring EEGs and MGMT with fluorescence. The purpose of the two parts is to create accurate representation of the data to determine the progress of glioblastoma.